inhibition of translation in various mammalian cells (Jefferies et al., , 1997 Terada et al., 1994 ; Beretta Hormones and growth factors induce protein trans Jefferies and Thomas, 1996) . Rapamycin lation in part by phosphorylation of the eukaryotic inhibits G 1 cell cycle progression as a consequence of initiation factor 4E (eIF4E) binding protein 1 (4E-BP1).
decreases in mRNA translation (Brown et al., 1994 ; Brown The rapamycin and FK506-binding protein (FKBP) and Schreiber, 1996) . In concert with these findings, the target 1 (RAFT1, also known as FRAP) is a mammalian yeast target of rapamycin (TOR) regulates G 1 progression homolog of the Saccharomyces cerevisiae target of through a translational mechanism (Barbet et al., 1996) . rapamycin proteins (mTOR) that regulates 4E-BP1.
The rapamycin-FKBP complex binds to FKBPHowever, the molecular mechanisms involved in growth rapamycin-associated protein (FRAP) in humans, factor-initiated phosphorylation of 4E-BP1 are not rapamycin and FKBP12 target (RAFT1) in rats and TOR well understood. Here we demonstrate that protein in yeast (Heitman et al., 1991; Kunz et al., 1993 ; Brown kinase Cδ (PKCδ) associates with RAFT1 and that et al., 1994; Sabatini et al., 1994; Stan et al., 1994 ; Sabers PKCδ is required for the phosphorylation and inactiva et al., 1995) . RAFT1 is a 220 kDa polypeptide that tion of 4E-BP1. PKCδ-mediated phosphorylation of contains at the C-terminus a protein and/or lipid kinase 4E-BP1 is wortmannin resistant but rapamycin sensitcatalytic domain, most closely related to those of the ive. As shown for serum, phosphorylation of 4E-BP1 DNA-dependent protein kinase (DNA-PK) and the ataxiaby PKCδ inhibits the interaction between 4E-BP1 telangectasia mutated (ATM), MEC1 and Tel1 checkpoint and eIF4E and stimulates cap-dependent translation.
gene products, and somewhat distantly related to that of the Moreover, a dominant-negative mutant of PKCδ phosphoinositide 3-kinase (PI3-K) (Keith and Schreiber, inhibits serum-induced phosphorylation of 4E-BP1.
1995). Mammalian TOR (mTOR) is an upstream regulator These findings demonstrate that PKCδ associates with
of 4E-BP1 phosphorylation (Brunn et al., 1997 ; Hara RAFT1 and thereby regulates phosphorylation Burnett et al., 1998; Gingras et al., 1999) .
4E-BP1 and cap-dependent initiation of protein trans-
Moreover, recent studies have shown that the PI3-Klation.
Introduction
in the signaling pathway that confers phosphorylation of 4E-BP1.
Growth factors and hormones induce translation of certain
The protein kinase C (PKC) family, a group of 11 known proteins that are essential for the proliferation and survival members that contain phospholipid-dependent serine/ responses of cells (Sonenberg, 1994 (Sonenberg, , 1996 threonine kinase activity, plays a key role in cellular 1995; Nielsen et al., 1995; Brown and Schreiber, 1996) . signal transduction and is involved in the regulation of However, little is known about signaling events that various cellular processes (Nishizuka, 1988 (Nishizuka, , 1995 ; Dekker connect growth stimuli to activation of the protein synand Parker, 1994) . PKC isoenzymes are differentially thesis machinery. Studies with rapamycin, an immunoexpressed and respond differently to physiological suppressive macrolide that interacts with the cytosolic inducers in diverse tissues and cell types (Dekker et al., (Kunz and Hall, 1995) . PKCδ is a novel PKC (nPKC) that is activated by 1993), have elucidated a signaling pathway that regulates protein synthesis in both animals and yeast (Barbet et al., diacylglycerol (DAG) or 12-O-tetradecanoylphorbol 13-acetate (TPA), but is unresponsive to Ca 2ϩ (Osada et al., 1992) . Recent work has demonstrated that insulin induces its proliferative effects in part through a PKCδ-dependent pathway (Reks et al., 1998) . Treatment of H4 hepatoma cells with insulin is associated with translocation of PKCδ from cytosol to membrane and thereby activation of PKCδ (Reks et al., 1998) . Recent studies have shown that phosphoinositidedependent kinase 1 (PDK1) is at the hub of many signaling pathways, activating Akt and PKC isoenzymes (Belham et al., 1999) . The activity of PDK1 expressed in mammalian cells is unaffected by stimuli that strongly activate Akt through PI3-K (Alessi et al., 1997) . Furthermore, recent studies have shown that PDK1 associates with rylation of PKCδ is independently regulated by a pathway involving mTOR/RAFT1 . Taken together, these findings demonstrate that serum-induced phosphorylation and activation of PKCδ is regulated by multiple upstream effectors.
Since phosphorylation and activation of PKCδ by serum and insulin is mediated by PI3-K→PDK1 signaling, we sought to determine whether PKCδ contributes to the regulation of the FRAP/mTOR→→4E-BP1 phosphorylation pathway and thereby mediates cap-dependent translation. The results demonstrate that PKCδ interacts with FRAP/mTOR and is required for phosphorylation of 4E-BP1 in vivo. The functional significance of the PKCδ-mTOR interaction is supported by the finding that PKCδ stimulates eukaryotic initiation factor 4E (eIF4E)- 
Results
PKCδ and the precipitates were analyzed by immunoblotting with anti-HA (top panel). Anti-HA immunoprecipitates were analyzed by
PKCδ constitutively associates with RAFT1
immunoblotting with anti-HA (middle panel). Lysates were also To determine whether PKCδ associates with RAFT1, analyzed by immunoblotting with anti-PKCδ (bottom panel). total cell lysates from 293T cells were subjected to immunoprecipitation with anti-PKCδ and the precipitates were analyzed by immunoblotting with anti-RAFT1. The necessary for the interaction with PKCδ, we transiently transfected HA-RAFT1 or a kinase-inactive HA-RAFT1 results demonstrate that PKCδ interacts constitutively with RAFT1 ( Figure 1A ). The finding that RAFT1 does not D2357E (RAFT1 D-E) mutant (Burnett et al., 1998) with PKCδ in 293T cells. Anti-PKCδ immunoprecipitates were interact with DNA-PK supports a specific interaction between PKCδ and RAFT1 (data not shown). To confirm analyzed by immunoblotting with anti-HA. As controls, anti-HA and anti-PKCδ immunoprecipitates were analyzed the interaction of PKCδ with RAFT1, 293T cells were transiently transfected with hemagglutanin (HA)-RAFT1.
by immunoblotting with anti-HA and anti-PKCδ, respectively. The association of RAFT1 and PKCδ was detected Anti-PKCδ immunoprecipitates from cytoplasmic extracts were analyzed by immunoblotting with anti-HA. Extracts in cells overexpressing HA-RAFT1 or HA-RAFT1 D-E (Figure 2 ). To determine whether the association of PKCδ were also subjected to incubation with pre-immune rabbit serum (PIRS) or anti-HA as controls. Reactivity of antiwith RAFT1 is dependent on the kinase function of PKCδ, 293T cells were transfected with PKCδ DR144/145A PKCδ with a Ͼ200 kDa protein supported the coprecipitation of RAFT1 with PKCδ ( Figure 1B) . In a reciprocal mutant and HA-RAFT1 or HA-RAFT1 D2357E. PKCδ DR144/145A harbors two amino acid substitutions in its experiment, anti-HA immunoprecipitates were analyzed by immunoblotting with anti-PKCδ. The results confirmed pseudosubstrate region (Hirai et al., 1994) , and thereby functions as a highly active kinase compared with fullthe presence of RAFT1 in a cytoplasmic complex of PKCδ ( Figure 1C ).
length PKCδ (PKCδ FL) (data not shown). Total cell lysates were subjected to immunoprecipitation with antiTo determine whether the kinase function of RAFT1 is PKCδ and analyzed by immunoblotting with anti-HA. The results demonstrate that PKCδ DR144/145A associates both with wild-type as well as the D2357E mutant of RAFT1 (Figure 2 ). Taken together, these findings indicate that the interaction of PKCδ and RAFT1 is independent of the kinase functions of RAFT1 and PKCδ.
PKCδ mediates the phosphorylation of 4E-BP1
To assess in part the functional significance of the interaction of PKCδ and RAFT1, we investigated whether RAFT1 is a substrate for PKCδ. To address this issue, 293T cells were transfected with vectors expressing HA-RAFT1 or the HA-RAFT1 D2357E mutant. Cell lysates were subjected to immunoprecipitation with anti-HA and half of the protein precipitates were incubated with the constitutively active glutathione S-transferase (GST)-PKCδ catalytic fragment (PKCδ CF) fusion protein (Emoto et al., 1995) in the presence of [γ-32 P]ATP. As a control, the precipitates were also incubated with a kinase-inactive GST-PKCδ CF(K-R) mutant. Analysis of the reaction products demonstrated that, in contrast to myelin basic protein (MBP), RAFT1 (wild type or D2357E) is not phosphorylated by PKCδ (data not shown). To assess the amount of RAFT1 protein, the precipitates were also analyzed by immunoblotting with anti-HA. Detection of RAFT1 protein in the anti-HA immunoprecipitates ruled out the possibility of substrate limitation (data not shown). These findings indicate that RAFT1 is not a substrate of PKCδ in vitro. (Burnett et al., 1998; Gingras et al., 1998 vector, PKCα R22A/A25E or PKCδ DR144/145A (right panel). Cells were serum starved for 48 h. Lysates were resolved by SDS-PAGE (Ueda et al., 1996) of 4E-BP1 and thereby a shift in its mobility ( Figure 3A ). Since PKCδ FL, but not PKCδ DR144/145A, failed to induce phosphorylation of 4E-BP1, we assessed the with the kinase-active PKCδ CF into 293T cells. As a control, an empty vector or a kinase-dead catalytic activity of PKCδ after transfecting FL or DR144/145A. In contrast to PKCδ DR144/145A, overexpression of fragment of PKCδ (PKCδ CF K-R) were separately overexpressed with HA-4E-BP1. Cells were serum starved PKCδ FL followed by serum starvation was associated with little, if any, increase in PKCδ activity (data not for 48 h and then lysates were analyzed by immunoblotting with anti-HA. The results demonstrate that overexpression shown). However, treatment of starved cells with serum ϩ TPA was associated with an increase in the of PKCδ CF, but not empty vector or PKCδ CF(K-R), is associated with phosphorylation of 4E-BP1 ( Figure 3A ). kinase activity of transiently overexpressed PKCδ and an increase in phosphorylation of 4E-BP1 (data not shown).
These findings demonstrate that, in contrast to inactive forms of PKCδ or other isoforms of PKC (PKCβII and In this context, a recent study has shown that treatment of serum-starved cells with serum ϩ TPA is associated PKCα R22A/A25E), overexpression of an active form of PKCδ (PKCδ DR144/145A or PKCδ CF) is sufficient to with mTOR-mediated increases in PKCδ activity . To confirm a role for PKCδ in phosphorylainduce a mobility shift of 4E-BP1. Analysis of the results from replicative experiments indicate that there is a 4-to tion of 4E-BP1, we transiently cotransfected HA-4E-BP1 amounts ( Figure 4A, bottom panel) . The results also demonstrate that the 4E-BP1 in cells expressing PKCδ is retained by the eIF4E-bound resin to a greater extent than that in cells expressing the PKCδ DR144/145A mutant ( Figure 4A , upper panel). To confirm a role for PKCδ in regulating the interaction of 4E-BP1 and eIF4E, we transiently overexpressed PKCδ CF or PKCδ CF(K-R). Cells were serum starved for 48 h and then lysates were incubated with an m 7 GTP-coupled agarose resin. Bound proteins were eluted and analyzed by immunoblotting with anti-4E-BP1. The results demonstrate that overexpression of PKCδ CF, but not PKCδ CF(K-R) is associated with significant inhibition (50-55%) of the interaction between 4E-BP1 and eIF4E ( Figure 4B ). Taken together, these findings indicate that catalytic activity of PKCδ is required to inhibit the formation of 4E-BP1-eIF4E Translation of cap-dependent mRNAs is inhibited by DR144/145A and serum starved for 48 h. Lysates were incubated with m 7 GTP-agarose beads for 45 min at 4°C. After incubation, the binding of 4E-BP1 to eIF4E proteins were resolved by 15% SDS-PAGE and analyzed by 1996) and thereby abrogation of the interaction of eIF4E (LUC) (Craig et al., 1998) . Cotransfection of pcDNA3-LUC-pol-CAT with PKCβII had no effect on luciferase activity. In contrast, PKCδ DR144/145A induced the 5-fold increase in phosphorylation of 4E-BP1 by overexpressing active mutants of PKCδ. To assess whether expression of luciferase by Ͼ2-fold ( Figure 5A ). To assess further the role of PKCδ in stimulation of cap-dependent PKCδ directly phosphorylates 4E-BP1, in vitro kinase assays were performed in which a GST-4E-BP1 fusion translation, 293 cells were cotransfected with pcDNA3-LUC-pol-CAT and empty vector or PKCδ CF. Cells were protein was incubated with active or inactive PKCδ in the presence of [γ-32 P]ATP. The phosphorylated reaction serum starved for 48 h and the luciferase activity was measured in total cell lysates. The results demonstrate products were analyzed by SDS-PAGE and autoradiography. The results demonstrate that, in contrast to MBP that transfection of PKCδ CF, but not empty vector, is associated with induction of luciferase activity ( Figure 5A ). ( Figure 3B , right panel), there is little, if any, phosphorylation of GST-4E-BP1 by PKCδ ( Figure 3B , left panel).
To determine the specificity for PKCδ, 293 cells were cotransfected with pcDNA3-LUC-pol-CAT and PKCδ Previous studies have shown that anti-RAFT1/mTOR immunoprecipitates contain kinase activities that are DR144/145A or PKCα R22A/A25E. Cells were serum starved for 48 h and the luciferase activity was measured specifically targeted to the eIF4E-4E-BP1 complex and not free 4E-BP1 Heesom and in total cell lysates. The results demonstrate that transfection of PKCδ DR144/145A, but not PKCα R22A/A25E, Denton, 1999). To determine whether PKCδ phosphorylates 4E-BP1 complexed with eIF4E, 293 cells were serum is associated with induction of luciferase activity ( Figure 5B ). To exclude the possibility that the effects starved for 48 h and total cell lysates were subjected to precipitation with 7-methyl-GTP (m 7 GTP). eIF4E-4E-observed reflect differences in mRNA concentration, RNase protection assays were performed on RNAs BP1 complexes were then incubated with PKCδ CF in the presence of [γ-32 P]ATP and analyzed by SDS-PAGE extracted from parallel transfections using antisense GAPDH and luciferase probes ( Figure 5C ). There were and autoradiography. The results demonstrate that PKCδ has no detectable effect on phosphorylation of 4E-BP1 in no protected fragments for the transfer RNA control (data not shown), and only GAPDH mRNA was detected in a complex with eIF4E ( Figure 3C ). Thus, PKCδ is not likely to be a direct 4E-BP1 kinase.
mock-transfected cells ( Figure 5C ). The luciferase: GAPDH mRNA ratio for PKCδ DR144/145A was 1.09 Ϯ 0.17 relative to PKCδ FL (normalized at 1).
PKCδ inhibits the ability of 4E-BP1 to interact with eIF4E and stimulates cap-dependent initiation of The luciferase:GAPDH mRNA ratio for PKCδ CF was 1.16 Ϯ 0.22 relative to PKCδ CF(K-R) (normalized at 1)
protein translation
Since PKCδ stimulates phosphorylation of 4E-BP1, we ( Figure 5C ). To confirm the effects of PKCδ on capdependent initiation of protein translation, we cotransasked whether PKCδ regulates the interaction of 4E-BP1 with eIF4E. To address this issue, 293 cells were transiently fected cells with pcDNA3-LUC-pol-CAT and increasing amounts of PKCδ DR144/145A. Cells were serum starved transfected with PKCδ FL or PKCδ DR144/145A. After serum starvation for 48 h, the cells were lysed and the for 48 h before assessing luciferase activity. Transfection of PKCδ DR144/145A was associated with a dose-dependent lysates were incubated with an m 7 GTP-coupled agarose resin. Bound proteins were eluted and analyzed by immuincrease in luciferase activity compared with that obtained for the vector alone ( Figure 5D ). Collectively, these noblotting with anti-4E-BP1. As expected, eIF4E, which recognizes the cap structure, bound to the resin in equal findings indicate that overexpression of active forms starved for 48 h and total lysates were analyzed by luciferase activity assays. The results demonstrate that overexpression of PKCδ DR144/145A with RAFT1 increases cap-dependent translation by~2.5-fold compared with vector ( Figure 6A ). Importantly, this increase in protein translation was inhibited by Ͼ50% in cells coexpressing PKCδ DR144/145A and RAFT1 D2357E ( Figure 6A ). Similar experiments were performed in which cells were transfected with PKCδ CF with or without RAFT1 D2357E. Cells were cotransfected with pcDNA3-LUC-pol-CAT, serum starved for 48 h and luciferase activity was measured in total lysates. The results demonstrate that the PKCδ CF-mediated increase in luciferase activity was significantly inhibited by overexpression of RAFT1 D2357E ( Figure 6A ). To confirm a role for PKCδ-RAFT1 complexes in regulating the interaction of 4E-BP1 and eIF4E, we transiently cotransfected PKCδ DR144/145A, PKCδ CF or PKCδ CF(K-R) with RAFT1 or RAFT1 D2357E. Cells were serum starved for 48 h and lysates were incubated with m 7 GTP-coupled agarose resin. Bound proteins were eluted and analyzed by immunoblotting with anti-4E-BP1. The results demonstrate that, in contrast to RAFT1 D2357E, overexpression of PKCδ DR144/145A or PKCδ CF with RAFT1 wild type is associated with significant inhibition (45-55%) of the interaction between 4E-BP1 and eIF4E ( Figure 6B ). is resistant to wortmannin and sensitive to rapamycin ( Figure 6D ). There was 67 Ϯ 6.8% (mean Ϯ SD of three independent experiments) inhibition of the PKCδ DR144/ PKCδ-mediated, cap-dependent translation requires RAFT1 activity and is resistant to 145A-mediated increase in phosphorylation of 4E-BP1 by rapamycin ( Figure 6D , bottom panel). This effect is similar wortmannin and sensitive to rapamycin 4E-BP1 phosphorylation and cap-dependent translation to that observed previously for Akt . Taken together, these findings support a pathway that are mediated by the RAFT1 signaling pathway both in yeast and mammalian cells (Barbet et al., 1996; Beretta (i) involves activation of PI3-K and thereby stimulation of PKCδ and Akt through PDK1 (Le Good et al., 1998); Burnet et al., 1998; Gingras et al., 1998; Hara et al., 1997) . To determine whether a dominantand (ii) confers phosphorylation of 4E-BP1. The findings also indicate that RAFT1 activity is required, at least in negative mutant of RAFT1 (RAFT1 D2357E) inhibits PKCδ DR144/145A-mediated increases in cap-dependent part, for PKCδ-dependent initiation of protein translation. translation, cells were transfected with vector, RAFT1 wild type, RAFT1 D2357E, PKCδ DR144/145A, PKCδ Role of PKCδ in phosphorylation of 4E-BP1 and regulation of cap-dependent translation in vivo DR144/145A ϩ RAFT1 D2357E or PKCδ DR144/ 145A ϩ RAFT1. Cells were cotransfected with pcDNA3-Previous studies have indicated a role for PI3-K and Akt(PKB) kinase in the phosphorylation of 4E-BP1 by LUC-pol-CAT. Following transfection, cells were serum (A) MCF-7/GFP and MCF-7/GFP-PKCδ-RD cells were transfected with pcDNA3-LUC-pol-CAT. Cells were serum starved for 36 h and stimulated with serum in the presence or absence of 50 ng/ml rapamycin for an additional 12 h. Lysates were assayed for luciferase activity. Luciferase activity is expressed as percentage control (mean Ϯ SD of three independent experiments). Total cell lysates from The results are expressed as percentage 4E-BP1 phosphorylation DR144/145A ϩ RAFT1 D2357E (bar 6). Cells were serum starved for (mean Ϯ SD) of two independent experiments (lower panel). (C) 293 48 h and lysates were assayed for luciferase activity. Luciferase cells were transfected with vector or GFP-PKCδ-RD. Total cell lysates activity is expressed as percentage control (mean Ϯ SD of three were subjected to immunoprecipitation with anti-PKCδ and the independent transfections). 293 cells were cotransfected with pcDNA3-precipitates were incubated with MBP in the presence of [γ-32 P]ATP. LUC-pol-CAT (2 µg) and vector or PKCδ CF in the presence or
The reaction products were analyzed by SDS-PAGE and autoabsence of HA-RAFT1 D2357E. Cells were serum starved for 48 h radiography (top panel). Anti-PKCδ immunoprecipitates were analyzed and lysates were assayed for luciferase activity. (von Manteuffel et al., 1996;  by immunoblotting with anti-HA (left panel). Right panel: 293 cells Gingras et al., 1998) . Moreover, the effects of serum or were also separately cotransfected with HA-4E-BP1 and insulin on 4E-BP1 phosphorylation in vivo are mediated PKCδ CF ϩ RAFT1 D-E (lane 1) or PKCδ CF ϩ RAFT1 wild type by RAFT1 (Beretta et al., 1996; Brunn et al., 1997;  (lane 2). Lysates were incubated with m 7 GTP resin and the precipitates were analyzed by immunoblotting with anti-HA. (C) 293 Gingras et al., 1998) . To examine whether PKCδ regulates cells were cotransfected with pcDNA3-LUC-pol-CAT (2 µg) and cap-dependent translation in vivo, we generated an 
GFP-PKCδ-RD protein with anti-GFP demonstrated that
Lysates were analyzed by immunoblotting with anti-HA (top panel).
MCF-7/GFP-PKCδ-RD cells overexpress this protein
The results are expressed as percentage inhibition (mean Ϯ SD) of three independent experiments (bottom panel).
( Figure 7A, inset) . MCF-7/GFP and MCF-7/GFP-PKCδ-RD cells were transiently transfected with pcDNA3-LUCpol-CAT. After transfection, the cells were deprived of serum for 36 h and then stimulated with serum for 12 h. The results demonstrate that the serum-induced increase in luciferase activity is partially inhibited in cells overexpressing GFP-PKCδ-RD ( Figure 7A ). Previous studies have shown that Akt inhibits the binding of 4E-BP1 to eIF4E and thereby stimulates cap-dependent translation . The partial inhibition in seruminduced, cap-dependent translation by PKCδ-RD observed in the present study therefore supports the role of Akt in contributing to this effect. Serum-starved MCF-7/GFP or MCF-7/GFP-PKCδ-RD cells were also stimulated with serum in the presence and absence of rapamycin. As expected, the results demonstrate that treatment of cells with rapamycin inhibited serum-induced, cap-dependent translation in vivo ( Figure 7A) . To extend the analysis of PKCδ in cap-dependent translation in vivo, MCF-7/GFP and MCF-7/GFP-PKCδ-RD cells were serum starved for 36 h. Serum was added for 45 or 90 min and lysates were analyzed by immunoblotting with anti-4E-BP1. The results demonstrate that serum-induced phosphorylation of endogenous 4E-BP1 is partially inhibited in cells expressing GFP-PKCδ-RD ( Figure 7B ). To demonstrate whether PKCδ-RD specifically inhibits endogenous PKCδ activity, (Gschwendt et al., 1994) . Cells were serum starved for incubation with anti-PKCδ (filled bars) or anti-Akt (hatched bars). ( Figure 8A ). Lysates were also incubated with an m 7 GTPcoupled agarose resin. Bound proteins were eluted and 1995; Abraham, 1996; Thomas and Hall, 1997) . Few insights, however, are available regarding regulation of analyzed by immunoblotting with anti-4E-BP1. 4E-BP1 the catalytic function of PIK-related kinases. Recent was retained by the eIF4E-bound resin in cells pretreated studies have demonstrated that PKCδ constitutively interwith rottlerin, but not in the absence of the PKCδ inhibitor acts with DNA-PKcs. The functional importance of this ( Figure 8B ). Taken together, these findings support a interaction is supported by the finding that PKCδ phosmodel in which the kinase function of PKCδ is required to phorylates and inhibits DNA-PKcs in response to DNA stimulate cap-dependent translation in vivo. To determine damage . Other studies have shown whether rottlerin specifically inhibits PKCδ, lysates were that treatment of cells with cytokines increases association subjected to immunoprecipitation with anti-PKCδ or of PKCδ with PI3-K (Ettinger et al., 1996) . Activation anti-Akt. In vitro immune complex kinase assays were loop phosphorylation of PKCδ in response to serum performed using MBP as substrate. The results demonstrate stimulation of cells is PI3-K dependent. These findings that pretreatment of 293T cells with rottlerin significantly have indicated that there are separate pools of PI3-K and inhibits serum-induced activation of PKCδ, and not Akt PKCδ (Le Good et al., 1998) . The present work extends ( Figure 8C) . the relationship between PKCδ and PIK family members with the demonstration that PKCδ binds constitutively
Discussion
and directly to RAFT1. The functional importance of the PKCδ-RAFT1 interaction is supported by the finding that PKCδ interacts with multiple members of the PIK this complex plays a role in the regulation of capfamily dependent initiation of protein translation. RAFT1/mTOR/FRAP is related to members of the PI3-kinase (PIK) family that include Tor1p, Tor2p, DNA-PK Role for PKCδ in phosphorylation of 4E-BP1 and catalytic subunit (DNA-PKcs), ATR (ataxia-telangiectasia cap-dependent initiation of protein translation related) and ATM, which are involved in cell cycle control Growth factors induce rapid increases in protein synthesis by stimulating mRNA translation (Sonenberg and Gingras, and DNA repair (Kunz et al., 1993; Keith and Schreiber, 1998) . The translation of mRNA into protein is controlled at several levels by hormones, growth factors and other stimuli. A major target of extracellular stimuli is the translation initiation factor eIF4E . The activity of eIF4E is controlled in part by 4E-BPs that interact with eIF4E in their hypophosphorylated, but not hyperphosphorylated, form Pause et al., 1994) . Recent studies have demonstrated that PI3-K is required for the phosphorylation and inactivation Fig. 9 . Schematic model depicting the role of the mTOR/FRAP/ of 4E-BP1 (Beretta et al., 1996; von Manteuffel et al., RAFT1-PKCδ complex in 4E-BP1-mediated, cap-dependent 1996) . However, other studies have shown that PI3-K is translation. PI3-K acts upstream to the mTOR/FRAP-Akt pathway not the direct kinase of 4E-BP1 (Scott et al., 1998) and . The present results demonstrate that overexpression of active PKCδ DR144/145A is associated with that it controls the activity of RAFT1, which is required induction in phosphorylation of 4E-BP1 and that this effect is for 4E-BP1 phosphorylation (Brunn et al., 1996) . Furtherinsensitive to wortmannin. These findings indicate that the mTOR/ more, previous studies have shown that Akt, which also FRAP-PKCδ complex lies downstream to PI3-K. Moreover, there is regulates 4E-BP1 phosphorylation, functions downstream no detectable interaction between Akt and PKCδ (data not shown). Our results and those from others indicate that of PI3-K . The present work demon-FRAP/mTOR functions as a scaffolding protein through which strates that PKCδ is required for the phosphorylation and expressed transiently in 293T cells. Moreover, we show that a constitutively active form of PKCδ induces phosphorylation of 4E-BP1 in the absence of growth factors ation of 4E-BP1 is inhibited by pretreatment with rapamycin, the rapamycin-sensitive component resides parallel to and that this effect is resistant to wortmannin. Taken together, these findings indicate that PKCδ acts down-PKCδ in this signaling cascade. The finding that PKCδ-mediated phosphorylation of 4E-BP1 is also inhibited by stream of PI3-K in mediating phosphorylation of 4E-BP1. In this context, recent studies have shown that addition a kinase-dead mutant of RAFT1 (RAFT1 D2357E) further indicates that PKCδ and RAFT1 activities are both required of serum to serum-starved cells is associated with activation of PKCδ by increasing its phosphorylation on the to stimulate phosphorylation of 4E-BP1 maximally. Recent work has shown that RAFT1 immunoprecipiactivation loop (Le Good et al., 1998) . Moreover, phosphorylation of the PKCδ activation loop by its upstream tated from cells is able to phosphorylate 4E-BP1 in vitro (Brunn et al., 1997) . However, this observation does not modulator is sensitive to PI3-K inhibitors (Le Good et al., 1998) . To assess the role of PKCδ in vivo, we generated preclude the possibility that a downstream effector of RAFT1 that coimmunoprecipitates with RAFT1 is a cell line that stably expresses the N-terminal regulatory domain of PKCδ (MCF-7/PKCδ-RD). Overexpression of responsible for 4E-BP1 phosphorylation. Taken together with the results of the present study, the findings suggest PKCδ-RD competes with the endogenous PKCδ for binding to its targets. The finding that serum-induced phosphothat PKCδ may not be a direct 4E-BP1-kinase in vivo, although kinase activities of RAFT1 and PKCδ are rylation of 4E-BP1 is significantly inhibited in cells expressing PKCδ-RD indicates that PKCδ mediates required to stimulate 4E-BP1 phosphorylation. Moreover, the large size of RAFT1 raises the possibility that it may phosphorylation of 4E-BP1 in vivo.
The translation of most eukaryotic mRNAs is mediated act as a scaffolding protein that can interact with multiple kinases. Thus, one of these kinases could be PKCδ. by cap-dependent mechanisms (Jackson, 1993) . Unphosphorylated 4E-BP1 interacts with eIF4E and thereby Therefore, the available evidence supports a model in which the RAFT1-PKCδ complex plays an active role inhibits cap-dependent translation . 4E-BP1 phosphorylation and cap-dependent translation in 4E-BP1 phosphorylation and 4E-BP1-mediated, capdependent initiation of protein translation (Figure 9 ). are mediated by RAFT1 signaling in yeast and mammalian cells (Barbet et al., 1996; Beretta et al., 1996; Burnett et al., 1998; Gingras et al., 1998; Hara et al., 1997) .
Function for PKCδ in cell proliferation and apoptosis
Moreover, inhibition of RAFT1 activity by the rapamycin-FKBP12 complex contributes to translational arrest by PKCδ belongs to the nPKC group and is activated by DAG by a calcium-independent mechanism. Activation of increasing the affinity of 4E-BP1 for eIF4E (Brown et al., 1995; Hara et al., 1997) . Other than the rapamycinthe platelet-derived growth factor (PDGF) and epidermal growth factor (EGF) receptors is associated with induction FKBP12 complex, there are no known inhibitors of RAFT1 activity. The results of the present study demonstrate that of PKCδ (Li et al., 1994; Denning et al., 1996) . Moreover, transformation by Ras or v-Src results in activation of overexpression of activated forms of PKCδ (PKCδ DR144/ 145A mutant and PKCδ CF) inhibits the interaction of PKCδ (Denning et al., 1993; Zang et al., 1997) . In contrast, other studies have shown that in response to 4E-BP1 with eIF4E. Other studies have shown that an activated form of Akt (Myr-Akt) also inhibits the binding stress, PKCδ is involved in the induction of growth arrest and apoptosis (Watanabe et al., 1992; Emoto et al., 1995; of 4E-BP1 to eIF4E (Gingras et al., 1998) .
The present results demonstrate that PKCδ coimmuno- Ghayur et al., 1996; ). An apparent paradox with regard to the role of PKCδ in precipitates with RAFT1 and thereby potentiates the phosphorylation of 4E-BP1. Since PKCδ does not directly apoptosis in response to stress, however, is raised by the recent finding that activation loop phosphorylation of phosphorylate RAFT1, and PKCδ-mediated phosphoryl-(Santa Cruz) antibodies. The protein precipitates were assayed for kinase PKCδ in response to serum stimulation of cells is PI3-K activity as described (Kharbanda et al., 1996) . dependent and mediated by PDK1 (Le Good et al., 1998 (Rousseau et al., 1996) , protein precipitation with m 7 GTP resin. The precipitates were then it is possible that the growth-mediated effects of PKCδ incubated with active PKCδ CF in the presence of [γ-32 P]ATP and kinase are governed, at least in part, by phosphorylation of 4E-buffer at 30°C for 20 min. The reaction products were analyzed by SDS-PAGE and autoradiography.
BP1 and thereby activation of eIF4E. Because of potential roles for PKCδ in both cell proliferation and survival, its m 7 GTP and eIF4E affinity chromatography downstream targets in the proliferative response might be To purify endogenous eIF4E, 50 µl of a 50% slurry of m 7 GTP Sepharose different from its targets in response to stress.
were added to the lysate and the mixture was incubated for 45 min at 4°C. After washing the resin twice with 50 mM HEPES pH 7.4, 50 mM NaCl, 2 mM EDTA, 0.1% Triton X-100, bound proteins were eluted
Materials and methods
and analyzed by SDS-PAGE and immunoblotting with anti-HA or anti-4E-BP1. Cell culture and reagents 293, 293T, MCF-7, MCF-7/GFP and MCF-7/PKCδ-RD cells were grown as described (Kharbanda et al., 1995b) . Cells were treated with Luciferase activity assays 20-50 ng/ml rapamycin (Sigma), 200 nM wortmannin (Sigma) or 10 µM 293T cells were transiently transfected with the plasmid pcDNA3-LUCrottlerin (Calbiochem).
pol-CAT (Beretta et al., 1996 , Craig et al., 1998 using the calcium phosphate method as described . After transfection, Antibodies and other reagents cells were serum starved for 24 h. Serum was added for 12 h with or The antibodies used were from the following sources: anti-HA, without 20 ng/ml rapamycin. Cell extracts were prepared and assayed Boehringer Mannheim; anti-PKCδ and anti-PKCβ, Santa Cruz Biotechfor luciferase activity in a luminometer (Turner) using an Enhanced nology (Santa Cruz, CA); anti-P-Tyr, Upstate Biotechnology Inc., (UBI, Luciferase Assay Kit (Analytical Luminescence Laboratories, Ann Upstate, NY); anti-4E-BP1, clone 11208 . m 7 GTP Arbor, MI). coupled to agarose resin was purchased from Pharmacia Biotech (Uppsala, Sweden).
Isolation of RNA and RNase protection assays Forty-eight hours after cell transfection, total RNA was isolated using Plasmids the single-step guanidinium isothiocyanate method as described (Kumar FL, CF and CF(K-R) of PKCδ were as described Carmichael, 1997) . Internally labeled RNA probes were made by pGEX-PKCδ FL, pGEX-PKCδ CF, pGEX-PKCδ CF(K-R), pEGFPin vitro transcription by T3 or T7 RNA polymerase in the presence of PKCδ CF and pEGFP-PKCδ CF(K-R) were as described (Bharti et al., [α-32 P]UTP as described (Kumar and Carmichael, 1997) . In brief, DNA 1998). HA-RAFT1 and HA-RAFT1 D2357E (Sabatini et al., 1994;  templates were removed by RQ1 DNase digestion followed by phenol/ Burnett et al., 1998) , 4E-BP1 cDNA and pCDNA3-chloroform extraction. RNA was hybridized overnight to 32 P-labeled Luc-Pol-CAT were as described (Craig et al., 1998) . PKCδ DR144/ antisense RNA probes specific for GAPDH (Pharmingen, San Diego, 145A and PKCα R22A/A25E expression vectors were provided by CA) and luciferase as described (Donze et al., 1995; Kumar and S.Ohno (Ueda et al., 1996) . The pE1-PKCβII expression plasmid was Carmichael, 1997). constructed as described (Kaneki et al., 1999) .
Transient transfections
Cells were grown in 100-mm cell culture dishes and were transiently
